166 related articles for article (PubMed ID: 36871535)
1. Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era.
Mao L
Int Immunopharmacol; 2023 Apr; 117():109952. PubMed ID: 36871535
[TBL] [Abstract][Full Text] [Related]
2. Thymosin alpha 1 treatment for patients with sepsis.
Pei F; Guan X; Wu J
Expert Opin Biol Ther; 2018 Jul; 18(sup1):71-76. PubMed ID: 30063866
[TBL] [Abstract][Full Text] [Related]
3. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells.
Liu Y; Pan Y; Hu Z; Wu M; Wang C; Feng Z; Mao C; Tan Y; Liu Y; Chen L; Li M; Wang G; Yuan Z; Diao B; Wu Y; Chen Y
Clin Infect Dis; 2020 Nov; 71(16):2150-2157. PubMed ID: 32442287
[TBL] [Abstract][Full Text] [Related]
4. Thymosin alpha1. SciClone Pharmaceuticals.
Billich A
Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
[TBL] [Abstract][Full Text] [Related]
5. Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection.
Minutolo A; Petrone V; Fanelli M; Maracchioni C; Giudice M; Teti E; Coppola L; Sorace C; Iannetta M; Tony Miele M; Bernardini S; Mastino A; Sinibaldi Vallebona P; Balestrieri E; Andreoni M; Sarmati L; Grelli S; Garaci E; Matteucci C
Int Immunopharmacol; 2023 May; 118():110055. PubMed ID: 36989892
[TBL] [Abstract][Full Text] [Related]
6. Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application.
Tao N; Xu X; Ying Y; Hu S; Sun Q; Lv G; Gao J
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110771
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections.
Bellet MM; Renga G; Pariano M; Stincardini C; D'Onofrio F; Goldstein AL; Garaci E; Romani L; Costantini C
Int Immunopharmacol; 2023 Apr; 117():109949. PubMed ID: 36881979
[TBL] [Abstract][Full Text] [Related]
8. Historical review of thymosin α 1 in infectious diseases.
Camerini R; Garaci E
Expert Opin Biol Ther; 2015; 15 Suppl 1():S117-27. PubMed ID: 26098768
[TBL] [Abstract][Full Text] [Related]
9. Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysis.
Guo CL; Mei JD; Jia YL; Gan FY; Tang YD; Liu CW; Zeng Z; Yang ZY; Deng SY; Sun X; Liu LX
Chin Med J (Engl); 2021 Nov; 134(22):2700-2709. PubMed ID: 34732663
[TBL] [Abstract][Full Text] [Related]
10. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients.
Wang Z; Chen J; Zhu C; Liu L; Qi T; Shen Y; Zhang Y; Xu L; Li T; Qian Z; Steinhart CR; Lu H
Front Immunol; 2021; 12():568789. PubMed ID: 34149679
[TBL] [Abstract][Full Text] [Related]
11. Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model.
Ricci D; Etna MP; Severa M; Fiore S; Rizzo F; Iannetta M; Andreoni M; Balducci S; Stefanelli P; Palamara AT; Coccia EM
Int Immunopharmacol; 2023 Apr; 117():109996. PubMed ID: 36933449
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells.
Wang S; Huang M; Chen M; Sun Z; Jiao Y; Ye G; Pan J; Ye W; Zhao J; Zhang D
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37295817
[TBL] [Abstract][Full Text] [Related]
13. Thymalfasin for the treatment of chronic hepatitis B.
Chien RN; Liaw YF
Expert Rev Anti Infect Ther; 2004 Feb; 2(1):9-16. PubMed ID: 15482167
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.
Wu J; Zhou L; Liu J; Ma G; Kou Q; He Z; Chen J; Ou-Yang B; Chen M; Li Y; Wu X; Gu B; Chen L; Zou Z; Qiang X; Chen Y; Lin A; Zhang G; Guan X
Crit Care; 2013 Jan; 17(1):R8. PubMed ID: 23327199
[TBL] [Abstract][Full Text] [Related]
15. A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection.
Shehadeh F; Benitez G; Mylona EK; Tran QL; Tsikala-Vafea M; Atalla E; Kaczynski M; Mylonakis E
J Infect Dis; 2023 Jan; 227(2):226-235. PubMed ID: 36056913
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials.
Dinetz E; Lee E
Altern Ther Health Med; 2024 Jan; 30(1):6-12. PubMed ID: 38308608
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with thymosin alpha1 and dexamethasone helps mice survive sepsis.
Xiang XS; Li N; Zhao YZ; Li QR; Li JS
Inflammation; 2014 Apr; 37(2):402-16. PubMed ID: 24122349
[TBL] [Abstract][Full Text] [Related]
18. Historical review on thymosin α1 in oncology: preclinical and clinical experiences.
Garaci E; Pica F; Matteucci C; Gaziano R; D'Agostini C; Miele MT; Camerini R; Palamara AT; Favalli C; Mastino A; Serafino A; Sinibaldi Vallebona P
Expert Opin Biol Ther; 2015; 15 Suppl 1():S31-9. PubMed ID: 26096345
[TBL] [Abstract][Full Text] [Related]
19. Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing.
Bai H; Liang L; Qi X; Xu Y; Liu Y; Ren D; Cai Z; Mao W; Wang X; Qin H; Hu F; Shi B
Int Immunopharmacol; 2023 Nov; 124(Pt B):110983. PubMed ID: 37769533
[TBL] [Abstract][Full Text] [Related]
20. Effect of ulinastatin combined with thymosin alpha1 on sepsis: A systematic review and meta-analysis of Chinese and Indian patients.
Liu D; Yu Z; Yin J; Chen Y; Zhang H; Xin F; Fu H; Wan B
J Crit Care; 2017 Jun; 39():259-266. PubMed ID: 28069319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
